Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 216

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy

Open access
Liebregts, Max, Vriesendorp, Pieter A., Mahmoodi, Bakhtawar K., Schinkel, Arend F.L., Michels, Michelle, ten Berg, Jurriën M. · 2015 · JACC: Heart Failure

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jchf.2015.06.011

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 62

  1. Maron, 2003, J Am Coll Cardiol, 42, 1687, 10.1016/S0735-1097(03)00941-0 · DOI · Paper page
  2. Morrow, 1975, Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients, Circulation, 52, 88, 10.1161/01.CIR.52.1.88 · DOI · Paper page
  3. Agarwal, 2010, Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy, J Am Coll Cardiol, 55, 823, 10.1016/j.jacc.2009.09.047 · DOI · Paper page
  4. Leonardi, 2010, Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy comparative rates of overall mortality and sudden cardiac death after treatment, Circ Cardiovasc Interv, 3, 97, 10.1161/CIRCINTERVENTIONS.109.916676 · DOI
  5. Brown, 2011, Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy, J Thorac Cardiovasc Surg, 141, 439, 10.1016/j.jtcvs.2010.04.046 · DOI
  6. Faber, 2005, Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society, Z Kardiol, 94, 516
  7. Fernandes, 2005, A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy–the Baylor experience (1996-2002), Clin Cardiol, 28, 124, 10.1002/clc.4960280305 · DOI
  8. Guo, 2004, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and three-year noninvasive follow-up in 18 patients, Can J Cardiol, 20, 779
  9. Jensen, 2011, Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study, Circ Cardiovasc Interv, 4, 256, 10.1161/CIRCINTERVENTIONS.110.959718 · DOI
  10. Jensen, 2011, Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy, Scand Cardiovasc J, 45, 153, 10.3109/14017431.2011.565793 · DOI
  11. Krejci, 2013, Comparison of long-term effect of dual-chamber pacing and alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy, Sci entificWorldJournal, 2013, 629650
  12. Malek, 2009, Long-term follow-up of patients with hypertrophic obstructive cardiomyopathy treated with percutaneous alcohol septal ablation, Post Kardiol Interw, 5, 167
  13. Minami, 2000, Long-term results after myectomy in 64 patients with hypertrophic obstructive cardiomyopathy (HOCM). Morphological and hemodynamic aspects, J Cardiovasc Surg (Torino), 41, 801
  14. Mohr, 1989, The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years, J Thorac Cardiovasc Surg, 97, 666, 10.1016/S0022-5223(19)34512-X · DOI
  15. Robbins, 1996, Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy, J Thorac Cardiovasc Surg, 111, 586, 10.1016/S0022-5223(96)70310-0 · DOI · Paper page
  16. Rothlin, 1983, Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy, Eur Heart J, 4, 215, 10.1093/eurheartj/4.suppl_F.215 · DOI
  17. Schulte, 1999, Management of symptomatic hypertrophic obstructive cardiomyopathy–long-term results after surgical therapy, Thorac Cardiovasc Surg, 47, 213, 10.1055/s-2007-1013146 · DOI
  18. Seggewiss, 2007, Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 96, 856, 10.1007/s00392-007-0579-8 · DOI
  19. Seiler, 1991, Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study, J Am Coll Cardiol, 17, 634, 10.1016/S0735-1097(10)80176-7 · doi:10.1016/s0735-1097(10)80176-7
  20. Shamim, 2002, Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy, N Engl J Med, 347, 1326, 10.1056/NEJMoa012710 · doi:10.1056/nejmoa012710
  21. Smedira, 2008, Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy, Ann Thorac Surg, 85, 127, 10.1016/j.athoracsur.2007.07.063 · DOI · Paper page
  22. Sorajja, 2013, Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Catheter Cardiovasc Interv, 81, 58
  23. Steggerda, 2014, Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience, J Am Coll Cardiol Intv, 7, 1227, 10.1016/j.jcin.2014.05.023 · DOI
  24. ten Berg, 1994, Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy, Circulation, 90, 1781, 10.1161/01.CIR.90.4.1781 · DOI
  25. ten Cate, 2010, Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution, Circ Heart Fail, 3, 362, 10.1161/CIRCHEARTFAILURE.109.862359 · DOI · Paper page
  26. Veselka, 2006, Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study, Circ J, 70, 1550, 10.1253/circj.70.1550 · doi:10.1253/circj.70.1550
  27. Sorajja, 2012, Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 126, 2374, 10.1161/CIRCULATIONAHA.111.076257 · DOI · Paper page
  28. Beahrs, 1983, Hypertrophic obstructive cardiomyopathy: ten- to 21-year follow-up after partial septal myectomy, Am J Cardiol, 51, 1160, 10.1016/0002-9149(83)90363-6 · doi:10.1016/0002-9149(83)90363-6
  29. Zhu, 2006, Surgical outcomes and strategy of hypertrophic obstructive cardiomyopathy, J Zhejiang Univ Sci B, 7, 148, 10.1631/jzus.2006.B0148 · doi:10.1631/jzus.2006.b0148
  30. Chen, 2006, Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication, Chin Med J, 119, 1121, 10.1097/00029330-200607010-00013 · doi:10.1097/00029330-200607010-00013
  31. Sathyamurthy, 2014, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up, Indian Heart J, 66, 57, 10.1016/j.ihj.2013.12.008 · doi:10.1016/j.ihj.2013.12.008
  32. de la Torre Hernandez, 2014, Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy, Rev Esp Cardiol, 67, 353, 10.1016/j.recesp.2013.09.005 · doi:10.1016/j.recesp.2013.09.005
  33. Fernandes, 2008, Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007, J Am Coll Cardiol Intv, 1, 561, 10.1016/j.jcin.2008.07.005 · DOI
  34. Guo, 2007, Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy, J Electrocardiol, 40, 356, 10.1016/j.jelectrocard.2006.12.003 · doi:10.1016/j.jelectrocard.2006.12.003
  35. Jensen, 2013, Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile, Heart, 99, 1012, 10.1136/heartjnl-2012-303339 · DOI
  36. Klopotowski, 2010, The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 99, 285, 10.1007/s00392-010-0116-z · DOI
  37. Lyne, 2010, Long-term follow-up of the first patients to undergo transcatheter alcohol septal ablation, Cardiology, 116, 168, 10.1159/000318307 · DOI
  38. Samardhi, 2014, The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy, Catheter Cardiovasc Interv, 83, 270
  39. Sedehi, 2015, Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy, J Cardiol, 66, 57, 10.1016/j.jjcc.2014.08.010 · DOI
  40. Veselka, 2014, Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population, Eur Heart J, 35, 2040, 10.1093/eurheartj/eht495 · DOI
  41. Vriesendorp, 2014, Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol HF, 2, 630
  42. Cohn, 1992, Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy, Am J Cardiol, 70, 657, 10.1016/0002-9149(92)90208-G · DOI
  43. Desai, 2013, Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction, Circulation, 128, 209, 10.1161/CIRCULATIONAHA.112.000849 · DOI · Paper page
  44. Gol, 1997, Septal myectomy in hypertrophic obstructive cardiomyopathy: late results with stress echocardiography, Ann Thorac Surg, 64, 739, 10.1016/S0003-4975(97)00633-4 · doi:10.1016/s0003-4975(97)00633-4
  45. Havndrup, 2000, Outcome of septal myectomy in patients with hypertrophic obstructive cardiomyopathy, Scand Cardiovasc J, 34, 564, 10.1080/140174300750064486 · DOI
  46. Heric, 1995, Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results, J Thorac Cardiovasc Surg, 110, 195, 10.1016/S0022-5223(05)80026-1 · DOI · Paper page
  47. Krajcer, 1989, Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients, Circulation, 80, 57
  48. Lisboa, 2011, Long term results of septal myectomy in the treatment of obstructive hypertrophic cardiomyopathy, Rev Bras Cir Cardiovasc, 26, 86, 10.1590/S0102-76382011000100016 · DOI
  49. Merrill, 2000, Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy, Ann Thorac Surg, 69, 1732, 10.1016/S0003-4975(00)01314-X · doi:10.1016/s0003-4975(00)01314-x
  50. Minami, 2002, Long term follow-up of surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM): the role of concomitant cardiac procedures, Eur J Cardiothorac Surg, 22, 206, 10.1016/S1010-7940(02)00254-3 · doi:10.1016/s1010-7940(02)00254-3
  51. Ommen, 2005, Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, 46, 470, 10.1016/j.jacc.2005.02.090 · DOI · Paper page
  52. Schonbeck, 1998, Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy, Ann Thorac Surg, 65, 1207, 10.1016/S0003-4975(98)00187-8 · DOI
  53. Schulte, 1993, Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years, J Thorac Cardiovasc Surg, 106, 709, 10.1016/S0022-5223(19)33715-8 · DOI
  54. Woo, 2005, Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy, Circulation, 111, 2033, 10.1161/01.CIR.0000162460.36735.71 · DOI · Paper page
  55. Kuhn, 2008, Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience, Clin Res Cardiol, 97, 234, 10.1007/s00392-007-0616-7 · DOI
  56. Sorajja, 2008, Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 118, 131, 10.1161/CIRCULATIONAHA.107.738740 · DOI · Paper page
  57. Alam, 2009, Hypertrophic obstructive cardiomyopathy alcohol septal ablation vs. myectomy: a meta-analysis, Eur Heart J, 30, 1080, 10.1093/eurheartj/ehp016 · DOI
  58. Zeng, 2006, Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a meta analysis, Int J Cardiol, 112, 80, 10.1016/j.ijcard.2005.10.009 · DOI
  59. Faber, 2004, Echo-guided percutaneous septal ablation for symptomatic hypertrophic cardiomyopathy: 7 years of experience, Eur J Echocardiogr, 5, 347, 10.1016/j.euje.2004.01.001 · DOI
  60. Drake, 2014, Echo-guided mitral reapair, Circ Cardiovasc Imaging, 7, 132, 10.1161/CIRCIMAGING.112.000458 · DOI
  61. Mohr, 2013, Keynote lecture-transmitral hypertrophic obstructive cardiomyopathy (HOCM) repair, Ann Cardiothorac Surg, 2, 729
  62. Khalpey, 2014, Robot-assisted septal myectomy for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction, J Thorac Cardiovasc Surg, 147, 1708, 10.1016/j.jtcvs.2013.12.017 · DOI

Cited by

See all 216

Metadata

Authors
Liebregts, M., Vriesendorp, P. A., Mahmoodi, B. K., Schinkel, A. F. L., Michels, M., & ten Berg, J. M.
Venue
JACC: Heart Failure
Publisher
Elsevier BV
Published
2015-11
Volume
3
Issue
11
Pages
896-905
ISSN
2213-1779 (ISSN-L)
OpenAlex
W1846550110
Cited by
216
References
2
FWCI
4.64
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy. https://app.cochat.ai/papers/10.1016/j.jchf.2015.06.011
The paper
Liebregts, M., Vriesendorp, P. A., Mahmoodi, B. K., Schinkel, A. F. L., Michels, M., & ten Berg, J. M. (2015). A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2015.06.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.